{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:32:30Z","timestamp":1791307950244,"version":"4.3.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,2,4]],"date-time":"2015-02-04T00:00:00Z","timestamp":1423008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1038\/leu.2015.26","type":"journal-article","created":{"date-parts":[[2015,2,4]],"date-time":"2015-02-04T07:34:06Z","timestamp":1423035246000},"page":"1781-1785","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Blocking programmed cell death 1 in combination with adoptive cytotoxic T-cell transfer eradicates chronic myelogenous leukemia stem cells"],"prefix":"10.1038","volume":"29","author":[{"given":"C","family":"Riether","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Gschwend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A-L","family":"Huguenin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C M","family":"Sch\u00fcrch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A F","family":"Ochsenbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,4]]},"reference":[{"key":"BFleu201526_CR1","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll DM . The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 2012; 12: 252\u2013264.","journal-title":"Nat Rev Cancer"},{"key":"BFleu201526_CR2","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nrc3317","volume":"12","author":"T O'Hare","year":"2012","unstructured":"O'Hare T, Zabriskie MS, Eiring AM, Deininger MW . Pushing the limits of targeted therapy in chronic myeloid leukaemia. Nat Rev Cancer 2012; 12: 513\u2013526.","journal-title":"Nat Rev Cancer"},{"key":"BFleu201526_CR3","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/stem.1597","volume":"32","author":"ML Guzman","year":"2014","unstructured":"Guzman ML, Allan JN . Concise review: leukemia stem cells in personalized medicine. Stem Cells 2014; 32: 844\u2013851.","journal-title":"Stem Cells"},{"key":"BFleu201526_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/cdd.2014.89","volume":"22","author":"C Riether","year":"2014","unstructured":"Riether C, Sch\u00fcrch CM, Ochsenbein AF . Regulation of hematopoietic and leukemic stem cells by the immune system. Cell Death Differ 2014; 22: 187\u2013198.","journal-title":"Cell Death Differ"},{"key":"BFleu201526_CR5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nri3191","volume":"12","author":"NP Restifo","year":"2012","unstructured":"Restifo NP, Dudley ME, Rosenberg SA . Adoptive immunotherapy for cancer: harnessing the T cell response. Nature Rev Immunol 2012; 12: 269\u2013281.","journal-title":"Nature Rev Immunol"},{"key":"BFleu201526_CR6","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","volume":"86","author":"HJ Kolb","year":"1995","unstructured":"Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995; 86: 2041\u20132050.","journal-title":"Blood"},{"key":"BFleu201526_CR7","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1084\/jem.20121229","volume":"210","author":"C Sch\u00fcrch","year":"2013","unstructured":"Sch\u00fcrch C, Riether C, Amrein MA, Ochsenbein AF . Cytotoxic T cells induce proliferation of chronic myeloid leukemia stem cells by secreting interferon-gamma. J Exp Med 2013; 210: 605\u2013621.","journal-title":"J Exp Med"},{"key":"BFleu201526_CR8","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1182\/blood-2008-09-179697","volume":"114","author":"S Mumprecht","year":"2009","unstructured":"Mumprecht S, Sch\u00fcrch C, Schwaller J, Solenthaler M, Ochsenbein AF . Programmed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progression. Blood 2009; 114: 1528\u20131536.","journal-title":"Blood"},{"key":"BFleu201526_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4049\/jimmunol.1102807","volume":"189","author":"W Hobo","year":"2012","unstructured":"Hobo W, Norde WJ, Schaap N, Fredrix H, Maas F, Schellens K et al. B and T lymphocyte attenuator mediates inhibition of tumor-reactive CD8+ T cells in patients after allogeneic stem cell transplantation. J Immunol 2012; 189: 39\u201349.","journal-title":"J Immunol"},{"key":"BFleu201526_CR10","doi-asserted-by":"publisher","first-page":"e55818","DOI":"10.1371\/journal.pone.0055818","volume":"8","author":"L Christiansson","year":"2013","unstructured":"Christiansson L, Soderlund S, Svensson E, Mustjoki S, Bengtsson M, Simonsson B et al. Increased level of myeloid-derived suppressor cells, programmed death receptor ligand 1\/programmed death receptor 1, and soluble CD25 in Sokal high risk chronic myeloid leukemia. PLoS One 2013; 8: e55818.","journal-title":"PLoS One"},{"key":"BFleu201526_CR11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/35004599","volume":"404","author":"K Akashi","year":"2000","unstructured":"Akashi K, Traver D, Miyamoto T, Weissman IL . A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 2000; 404: 193\u2013197.","journal-title":"Nature"},{"key":"BFleu201526_CR12","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ccr.2012.02.018","volume":"21","author":"B Zhang","year":"2012","unstructured":"Zhang B, Ho YW, Huang Q, Maeda T, Lin A, Lee SU et al. Altered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemia. Cancer Cell 2012; 21: 577\u2013592.","journal-title":"Cancer Cell"},{"key":"BFleu201526_CR13","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1084\/jem.187.5.763","volume":"187","author":"S Ehl","year":"1998","unstructured":"Ehl S, Hombach J, Aichele P, Rulicke T, Odermatt B, Hengartner H et al. Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunopathology. J Exp Med 1998; 187: 763\u2013774.","journal-title":"J Exp Med"},{"key":"BFleu201526_CR14","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1172\/JCI66301","volume":"123","author":"A Ghosh","year":"2013","unstructured":"Ghosh A, Dogan Y, Moroz M, Holland AM, Yim NL, Rao UK et al. Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activity. J Clin Invest 2013; 123: 2654\u20132662.","journal-title":"J Clin Invest"},{"key":"BFleu201526_CR15","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/sj.leu.2404522","volume":"21","author":"E Nadal","year":"2007","unstructured":"Nadal E, Garin M, Kaeda J, Apperley J, Lechler R, Dazzi F . Increased frequencies of CD4(+)CD25(high) T(regs) correlate with disease relapse after allogeneic stem cell transplantation for chronic myeloid leukemia. Leukemia 2007; 21: 472\u2013479.","journal-title":"Leukemia"},{"key":"BFleu201526_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/ajh.21915","volume":"86","author":"JM Gerber","year":"2011","unstructured":"Gerber JM, Qin L, Kowalski J, Smith BD, Griffin CA, Vala MS et al. Characterization of chronic myeloid leukemia stem cells. Am J H1ematol 2011; 86: 31\u201337.","journal-title":"Am J H1ematol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/leu201526.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/leu201526","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/leu201526.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:05:14Z","timestamp":1684433114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu201526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,4]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["BFleu201526"],"URL":"https:\/\/doi.org\/10.1038\/leu.2015.26","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,4]]},"assertion":[{"value":"4 February 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}